跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,067 条关于
“Reunion”
全部
1,067
临床试验
932
药物
47
机构
33
资讯
55
去年
Reunion Neuroscience Advances RE104 for Postpartum Depression and Adjustment Disorder
2年前
Reunion Neuroscience Advances RE104 Psychedelic Treatment for Postpartum Depression with $103M Funding
去年
Reunion Neuroscience Completes Patient Dosing in Phase 2 Trial of Novel Psychedelic for Postpartum Depression
2年前
Reunion Neuroscience Initiates Phase 2 Trial of Fast-Acting Psychedelic RE104 for Postpartum Depression
去年
Reunion Neuroscience to Launch REKINDLE Phase 2 Trial for Adjustment Disorder in Cancer Patients Using Psychedelic Therapy
8个月前
Reunion Neuroscience's RE104 Meets Primary Endpoint in Phase 2 Postpartum Depression Trial, Advances to Phase 3
去年
Reunion Neuroscience Completes Patient Dosing in Phase 2 RECONNECT Trial of RE104 for Postpartum Depression
去年
Knight Therapeutics to Acquire Paladin in $120 Million Strategic Pharmaceutical Deal
去年
Psychedelic Therapy Expands Beyond Cancer Care as Multi-Center Studies Launch
前天
Lipocine Launches Second Phase 3 BLOOM Trial of Oral Brexanolone LPCN 1154 in Postpartum Depression After First Pivotal Study Missed Endpoint
第 1 页,共 6 页
上一页
下一页